Volume 8, Issue 3 pp. 536-544
Full Access

Differential Expression of Ubiquitous and Neuronal Kinesin Heavy Chains During Differentiation of Human Neuroblastoma and PC12 Cells

G. Vignali

G. Vignali

CNR Cellular and Molecular Pharmacology Centre, Department of Medical Pharmacology, University of Milano, 20129 Milano, Italy

Search for more papers by this author
J. Niclas

J. Niclas

Department of Pharmacology and

Search for more papers by this author
M. T. Sprocati

M. T. Sprocati

CNR Cellular and Molecular Pharmacology Centre, Department of Medical Pharmacology, University of Milano, 20129 Milano, Italy

Search for more papers by this author
R. D. Vale

R. D. Vale

Department of Pharmacology and

Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, CA 94143, USA

Search for more papers by this author
C. Sirtori

C. Sirtori

CNR Cellular and Molecular Pharmacology Centre, Department of Medical Pharmacology, University of Milano, 20129 Milano, Italy

Search for more papers by this author
F. Navone

Corresponding Author

F. Navone

CNR Cellular and Molecular Pharmacology Centre, Department of Medical Pharmacology, University of Milano, 20129 Milano, Italy

Correspondence to: Dr F. Navone, as aboveSearch for more papers by this author
First published: March 1996
Citations: 20

Abstract

Kinesin is a microtubule-based motor protein involved in intracellular organelle transport. Neurons are characterized by the presence of at least two isoforms of conventional kinesin: ubiquitous kinesin, expressed in all cells and tissues, and neuronal kinesin, whose pattern of expression is confined to neuronal cells. In order to investigate whether the two kinesin motors, which are encoded by different genes, may play distinct biological roles in neurons, we studied their expression during neuronal differentiation. Human neuroblastoma SH-SY5Y and IMR32 cells and rat phaeochromocytoma PC12 cells were used as an in vitro system for neuronal differentiation and were induced to differentiate in the presence of retinoic acid, a combination of dibutyryl cAMP and 5-bromodeoxyuridine, and nerve growth factor respectively. The expression level of each kinesin isoform was evaluated by quantitative immunoblot before and after pharmacological treatment. We found that in all cell types the expression level of neuronal kinesin, but not of ubiquitous kinesin, is stimulated during differentiation. In particular, SH-SY5Y cells show a 4.5-fold, IMR32 cells a 3-fold and PC12 cells a 7-fold increase in the level of expression of neuronal kinesin. By Northern blot analysis we found that the selective increase in the expression of neuronal kinesin is paralleled by an increase in its mRNA, indicating that there is a transcriptional control of the expression of this kinesin isoform during differentiation of neuroblastoma and PC12 cells. Our results suggest that these cells represent an adequate model to study the function of conventional kinesin and its isoforms.

Abbreviations:

  • BrdU
  • 5-bromo-2′-deoxyuridine
  • Bt2cAMP
  • N-6, 2′,O-dibutyryladenosine 3′:5′-cyclic monophosphate
  • DMSO
  • dimethyl sulphoxide
  • EGTA
  • ethylene glycol-bis(β-aminoethyl ether)N, N, N', N'-(2-ethanesulphonic acid)
  • HEPES
  • N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulphonic acid)
  • NGF
  • nerve growth factor
  • nKHC
  • neuronal kinesin heavy chain
  • PAGE
  • polyacrylamide gel electrophoresis
  • uKHC
  • ubiquitous kinesin heavy chain
    • The full text of this article hosted at iucr.org is unavailable due to technical difficulties.